红花联合黄芪注射液治疗肝硬化失代偿期40例

目的：观察红花联合黄芪注射液用于失代偿期肝硬化的治疗疗效。方法：将40例失代偿期肝硬化患者随机分为治疗组和对照组。治疗组在常规治疗的基础上，另给予红花注射液和黄芪注射液静脉滴注；对照组采用常规治疗。观察实验室指标变化和治疗效果。结果：治疗组肝功指标ALT、AST、TBIL、ALB均较治疗前有显著改善（P〈0．05），对照组仅ALT、AST有改善（P〈0．05）；肝纤维化指标水平，治疗组治疗后较治疗前显著下降（P〈0．05），而且也显著低于对照组治疗后（P〈O．05）；治疗组总有效率为95．00％，对照组总有效率为65．00％，两组比较有显著性差异（P〈O．05）。结论：红花联合黄芪注射液能明显控制失代偿期肝硬化的炎症活动，治疗效果显著，值得临床推广应用。

Clinical Study of Safflower Injection Combined with Astragalus Injection Treatment in Patients with Decompensated Cirrhosis

Objective： To observe the clinical effects of Aafflower injection combined with Astragalus injection treatment in patients with decompensated cirrhosis （DC） . Methods： 40 cases patients were randomly divided into the treatment group and the control group. On the basis of conventional treatment, the treatment group was given the Aafflower injection and Astragalus injection intra- venous drip intravenous drip, the control group was given conventional therapy, and observation of the changes and treatment of labo- ratory results. Results： In the treatment group, the ALT, AST, TBIL, ALB and the level of liver fibrosis than before treatment have significantly improved （p 〈0.05） ; the total efficiency of 95.00% in the treatment group, but 65.00 % only in the control group, were significant difference （p 〈0.05） ; no adverse reaction. Conclusion： Aafflower injection combined with Astragalus injection can control DC of the inflammation, treatment significantly, worthy of clinical application.